Pier 88 Investment Partners LLC Takes Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Pier 88 Investment Partners LLC bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 1,170 shares of the company’s stock, valued at approximately $145,000. Other institutional investors have also modified their […]

Related Keywords

Alger ,Algeria ,United States ,Kathryn Romano ,Suma Krishnan ,William Blair ,Stifel Nicolaus ,First Turn Management ,Nasdaq ,Vanguard Group Inc ,Krystal Biotech Company Profile ,Investment Partners ,Fred Alger Management ,Securities Exchange Commission ,Jennison Associates ,Citigroup ,Krystal Biotech Inc ,Timessquare Capital Management ,Krystal Biotech ,Free Report ,Turn Management ,Alger Management ,Square Capital Management ,Biotech Trading Down ,Get Free Report ,Exchange Commission ,Visit Holdingschannel ,Krystal Biotech Daily ,